跳至主要内容
临床试验/NCT05849883
NCT05849883已完成不适用

Bioequivalence Study of 20 mg Omeprazole Capsules in Indonesia Healthy Subject

PT Kalbe Farma Tbk1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2020年12月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
1
主要终点
Geometric Mean Ratio of AUCt

研究概览

简要总结

The study was conducted to investigate whether 20 mg omeprazole capsules manufactured by PT. Dankos Farma for PT. Hexpharm Jaya is bioequivalent to its reference product, 20 mg Losec® capsules manufactured by AstraZeneca AB, Sweden, imported by PT. AstraZeneca Indonesia.

详细描述

Thirty six healthy subjects were given a single dose of 20 mg omeprazole capsules or 20 mg Losec® capsules with 240 mL of water. Then the blood samples for omeprazole were drawn and analyzed using LCMS/MS. All subjects sample plasma were analyzed for pharmacokinetic evaluation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 44 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Omeprazole 20 mg capsules

Experimental

Subjects were given a single dose of 20 mg omeprazole of either formulation (test or reference) with 240 ml of water

干预措施: Omeprazole 20 mg Capsules (Drug)

Losec® 20 mg capsules

Active Comparator

Subjects were given a single dose of 20 mg omeprazole of either formulation (test or reference) with 240 ml of water

干预措施: Omeprazole 20 mg Capsules (Drug)

结局指标

主要结局

Geometric Mean Ratio of AUCt

时间窗: before dosing and at 15, 30, 45, 60, 75, 90, 105 minutes, 2, 2.25, 2.5, 2.75, 3, 3.5, 4, 5, 6, 8, and 10 hours after drug administration

The ratio between area under curve from 0 to 10 hours of test drug and reference drug

Geometric Mean Ratio of Cmax

时间窗: before dosing and at 15, 30, 45, 60, 75, 90, 105 minutes, 2, 2.25, 2.5, 2.75, 3, 3.5, 4, 5, 6, 8, and 10 hours after drug administration

The ratio between maximum concentration of test drug and reference drug after drug administration

次要结局

  • Pharmacokinetics Parameter of Cmax(before dosing and at 15, 30, 45, 60, 75, 90, 105 minutes, 2, 2.25, 2.5, 2.75, 3, 3.5, 4, 5, 6, 8, and 10 hours after drug administration)
  • Pharmacokinetics Parameter of AUCt(before dosing and at 15, 30, 45, 60, 75, 90, 105 minutes, 2, 2.25, 2.5, 2.75, 3, 3.5, 4, 5, 6, 8, and 10 hours after drug administration)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Bioequivalence Study of 20 mg Omeprazole Capsules in... | 临床试验